Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
146.5 USD | +0.54% |
|
+0.22% | -6.55% |
Jul. 03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
Jul. 03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-6.55% | 353B | |
+56.89% | 823B | |
+39.52% | 627B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B | |
-2.57% | 159B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Transcript : Johnson & Johnson, Q1 2024 Earnings Call, Apr 16, 2024